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The prevalence of the postmastectomy pain syndrome (PMPS) and its clinical characteristics was assessed in a group of patients who
had undergone surgery for breast cancer at the Department of Surgery, Odense University Hospital, within the period of 1 May 2003
to 30 April 2004. The study included 258 patients and a reference group of 774 women. A questionnaire was mailed to the patients
11
2 year after surgery and to the women in the reference group. The PMPS was defined as pain located in the area of the surgery or
ipsilateral arm, present at least 4 days per week and with an average intensity of at least 3 on a numeric rating scale from 0 to 10. The
prevalence of PMPS was found to be 23.9%. The odds ratio of developing PMPS was 2.88 (95% confidence interval 1.84–4.51).
Significant risk factors were as follows: having undergone breast surgery earlier (OR 8.12), tumour located in the upper lateral quarter
(OR 6.48) and young age (OR 1.04). This study shows that, although recent advances in the diagnostic and surgical procedures have
reduced the frequency of the more invasive surgical procedures, there still is a considerable risk of developing PMPS after treatment
of breast cancer.
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Within the last decade, it has been increasingly accepted that
chronic pain can be a complication to surgery (Perkins and Kehlet,
2000; Macrae, 2001). Chronic pain has been reported after a range
of different types of surgery, such as thoracotomy, inguinal hernia
repair and hysterectomy.
Similarly, the prevalence of chronic pain after surgery for breast
cancer, the postmastectomy pain syndrome (PMPS), has been
known to develop in 20–68% of patients (Ivens et al, 1992;
Maunsell et al, 1993; Stevens et al, 1995; Tasmuth et al, 1995;
Wallace et al, 1996; Carpenter et al, 1998; Smith et al, 1999; Kuehn
et al, 2000; Peintinger et al, 2003).
The description, the postmastectomy pain syndrome, is some-
what misleading, as the syndrome also includes chronic pain
after breast conserving surgery. The exact mechanism of develop-
ment is not known, but it is probably a neuropathic pain
condition, which is because of damage to the nerves in the axilla
and/or the chest wall during surgery. On this basis, an alternative
term, intercostobrachial neuralgia, has been proposed (Jung et al,
2003). PMPS can develop shortly after surgery or up to several
months after surgery and can persist for years. Other causes
for chronic pain after treatment for breast cancer include
intercostal neuromas (Rosso et al, 2000; Wong, 2001; Kretschmer
et al, 2002).
The prevalence of PMPS has been shown to be higher after
lumpectomy than after mastectomy (Tasmuth et al, 1996, 1997).
The pain is often located in the axilla, the shoulder, the arm or the
chest wall. PMPS is often described as a typical neuropathic pain
consisting of burning pain, shooting pain, pain evoked by pressure
and deep blunt pain. Like other neuropathic pain conditions, the
treatment is often difficult. A study from 1994 and a recent study
suggest that the prognosis of PMPS is better than expected, with a
decline in prevalence over years (de Vries et al, 1994; Macdonald
et al, 2005).
Previous studies have identified following risk factors: young
age (Tasmuth et al, 1995; Smith et al, 1999; Poleshuck et al, 2006),
sectioning of the intercostobrachial nerve (Abdullah et al, 1998;
Torresan et al, 2003) and axillary dissection (Vecht, 1990; Maunsell
et al, 1993; Hack et al, 1999; Kakuda et al, 1999; Johansen et al,
2000). Dissection of axillary lymph nodes has been shown to be a
critical component in the aetiology of chronic pain after surgery
for breast cancer. The frequency of this procedure has been
reduced over the past few years, due to the introduction of the
sentinel node biopsy (Shons and Cox, 2001). The morbidity of this
procedure has been shown to be less than standard axillary
treatment (Kakuda et al, 1999; Schijven et al, 2003; Mansel et al,
2006). Thus, the prevalence of PMPS may have decreased (Miguel
et al, 2001). This study estimates the current prevalence of PMPS
and identifies risk factors.
MATERIALS AND METHODS
A postal survey concerning pain after surgery for breast cancer was
undertaken in the County of Funen, Denmark. Invitations to
participate, along with questionnaires, were mailed to a group of
breast cancer patients, 11
2 year after their surgery and to a group of
reference subjects. This time point was chosen to be sure to enrol
all chronic pain complaints and to avoid acute and transient
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spostoperative pain complaints. The inclusion criterion was as
follows: women who had undergone surgery for breast cancer with
either mastectomy or lumpectomy, performed at the Department
of Surgery, Odense University Hospital within the period from
1 May 2003 to 30 April 2004. The exclusion criteria were as follows:
(a) living outside the County of Funen, (b) having undergone
thoracotomy, (c) severe angina pectoris. Women with reoccur-
rence of breast cancer and women who had undergone breast
surgery earlier for cancer or cosmetic reasons were included in the
study.
The reference group was randomly selected from the same
general population as the breast cancer patients. For each breast
cancer patient, three reference subjects, who had not undergone
surgery for breast cancer, were selected as controls. The reference
group was established from the Danish Civil Registry and stratified
to the group of breast cancer patients on age and postal code.
A questionnaire was developed (available on request from the
authors). Questions about pain focused on present pain and pain
experienced in the week preceding the assessment. There were also
questions about the location, the intensity and the character of the
pain as well as the impact of pain on daily living, the consumption
of analgesics and demographic questions. The questionnaires were
tested for comments on colleagues and controls. Non-responders
received a reminder 1 month after the first mailing. If needed,
participants were contacted by telephone for clarifying responses.
The Ethical Committee of Vejle and Funen County (VF 20040191)
and the Danish Data Protection Agency (J.nr. 2004-41-4514)
approved the study, which was performed according to the
Declaration of Helsinki.
Information about the surgery and the postoperative treatment
for the group of breast cancer patients was obtained from the
DBCG registry (Danish Breast Cancer Cooperative Group), the
Department of Surgery and the Department of Oncology, Odense
University Hospital. Comparisons regarding demographic char-
acteristics were conducted using w
2 or Fisher’s exact test for
categorical data, and non-parametric Mann–Whitney U-test was
used for non-categorical data. Univariate logistic regression
analysis was applied for testing the possible risk factors. After-
wards, multiple regression analysis was applied for the analysis of
possible risk factors, and a priori the following variables were
included: age, chemotherapy, radiation therapy, mastectomy,
tumour located in the upper lateral quarter. Post hoc, it was
decided to add the following variables for the multivariate analysis:
having undergone breast surgery earlier, smoking and axillary
dissection. These variables were significant or near-significant risk
factors in the univariate analysis. Age and tumour size were non-
categorical variables. All other variables in the multiple regression
analysis were categorical variables. Concerning pain and pain
characteristics, odds ratios with 95% confidence interval were
calculated. Significance was defined as Po0.05. All analysis was
performed with the statistical program STATA version 8.
Individuals with missing information from the questionnaire were
excluded from the specific analysis.
For the group of breast cancer patients, the PMPS was defined as
pain located in the area of the surgery or the ispilateral arm,
present at least 4 days a week and with an intensity of 3 or more on
a numeric rating scale from 0 to 10 (0¼no pain and 10¼worst
possible pain).
RESULTS
Questionnaires were mailed to 258 breast cancer patients and 774
reference subjects. After one written reminder, 219 (84.9%) of the
breast cancer patients and 563 (72.7%) of the reference subjects
had returned the questionnaire (Figure 1). The percentages of
patients and controls who needed reminders were 16.4 and 15.8%,
respectively. The prevalence of PMPS in the group of breast cancer
patients was 23.9% and the prevalence of PMPS-like symptoms in
the reference group was 10.0%. The odds ratio for developing
PMPS after surgery for breast cancer was 2.88 (95% CI 1.84–4.51).
Demographic characteristics
There was no significant difference in age between the responders
of the breast cancer patients and the reference subjects (median
age being 61.1 (IQR 54.2–68.1) vs 60.3 (IQR 53.7–66.7). In the
reference group, the median age was younger for subjects who
reported pain similar to PMPS (median age being 55.9 (IQR 49.7–
61.8) vs 60.5 (IQR 54.1–66.8) (P¼0.003). For other demographic
characteristics, there were a higher proportion of subjects from the
reference group that had children and twice as many had a family
history of chronic pain conditions (Table 1). The characteristics
are shown in Table 1. Post hoc analysis showed that the odds ratio
for developing PMPS increased to 3.7 (95% CI 1.82–8.30) when
adjusting for family history. Positive family history increased the
risk of PMPS-like symptoms in both groups. However, as controls
were more likely to have a positive family history, this reduces the
difference in PMPS-like symptoms between cases and controls.
Risk factors
The results of both univariate and multiple logistic regression
analysis are shown in Table 2. When using multiple regression
analysis, three significant risk factors were identified: Having
undergone breast surgery earlier (OR 8.12), tumour located in the
upper lateral quarter (OR 6.48) and young age (OR 1.04). Not-
associated risk factors included the following: chemotherapy,
axillary dissection, mastectomy, smoking, tumour size and
radiation therapy.
The location and character of pain
The distribution of the location of pain and the character of pain in
the group of breast cancer patients with PMPS and in the reference
group is shown in Table 1. The majority of the breast cancer
patients with PMPS had pain located in the axilla/arm (80.8%) and
in the area of the scar (55.8%), and 75.0% of the patients had pain
in more than one location. These findings were significantly higher
than in the reference group. There were no significant differences
with respect to the character of pain.
The type of breast surgery, axillary intervention and
location of pain
The location of pain subdivided according to the type of breast
surgery and axillary intervention is shown in Table 3. When
applying logistic regression analysis, we found that the odds ratio
for developing pain in the mamma was 0.27 (95% CI 0.11–0.72) for
lumpectomy, 2.91 (95% CI 0.59–14.4) for sentinel node biopsy and
1.99 (95% CI 0.43–9.20) for axillary dissection. The odds ratio for
developing pain in the shoulder, axilla and arm was 0.76 (95% CI
0.36–1.58) for lumpectomy, 0.88 (95% CI 0.25–3.12) for sentinel
node biopsy and 1.84 (95% CI 0.58–5.83) for axillary dissection.
Taking mastectomy and lumpectomy together, the frequency of
pain in general and at any location increased with the extent of
axillary intervention (Table 4).
Radiation therapy and location of pain
In Table 5, the relation between radiation therapy and the location
of pain is shown. A higher frequency of pain was observed in the
three categories when the radiation therapy included the
supraclavicular fields and the axillary region.
The postmastectomy pain syndrome
OJ Vilholm et al
605
British Journal of Cancer (2008) 99(4), 604–610 & 2008 Cancer Research UK
C
l
i
n
i
c
a
l
S
t
u
d
i
e
sSystemic therapy
None of the patients received treatment with taxanes or aromatase
inhibitors.
Pain treatment
The frequency of consumption of analgesics did not differ
significantly between the two groups. Among the breast cancer
patients with PMPS, 38.5% reported use of analgesics compared
with 52.8% of the reference subjects with pain. The frequency of
analgesic consumption was compared between the two groups, the
options being ‘Every day’, ‘every other day’, ‘once a week’, ‘every
other week’ and ‘once a month’. The distribution of answers in the
strata did not differ significantly, P¼0.349.
The impact of pain on daily life
More breast cancer patients than reference subjects reported that
pain interfered with daily life ‘really much’ (1.4 vs 0.8%), ‘quite a
lot’ (4.6 vs 4.0%), ‘some’ (6.4 vs 1.5%) and ‘a little bit’ (9.2 vs 5.0%).
The distribution of answers in the strata differed between the two
groups (z¼3.52, P¼0.0004) (Figure 2).
When looking at the patients with pain, who reported pain
interfering ‘really much’ or ‘quite a lot’ (n¼13), a mean pain score
of 7.2 (range 3–10) on a numeric rating scale from 0–10 was
found. All 13 patients had pain in the shoulder/axilla/arm and
6 patients had, in addition to this, pain in the mamma. No other
Table 1 Demographics of all subjects included in the study and location
and character of pain in subjects from breast cancer group (52/219) and
reference group (48/563) with PMPS
Breast cancer
patients
Reference
subjects P-value
Demographics (%)
Married 65 66 0.78
Children* 88 94 0.04
Working 36 43 0.08
Smoking 26 26 0.91
Alcohol abuse 7 7 0.78
Family history of chronic pain
conditions*
91 8 o0.01
Location of pain (%)
Scar 56 0
Chest wall 35 21 0.14
Shoulder* 40 73 o0.01
Axilla/arm* 81 48 o0.01
Other 21 27 0.50
41 location* 75 48 o0.01
Character of pain (%)
Throbbing 42 48 0.52
Shooting 50 40 0.27
Burning 23 13 0.16
Oppressing 37 29 0.55
*Significant difference: Po0.05.
Women who have undergone surgery for breast cancer at 
Odense University Hospital, Denmark within the period 
of 1 May 2003 – 30 April 2004 
(N=270)
Excluded  (N= 12) 
Dead (N=7) 
Living outside Funen (N=5) 
Questionnaire
(N=258)
Returning the 
questionnaire
(N=219, 84.9%) 
Returning the 
questionnaire
(N=563, 72.7%) 
Questionnaire
(N=774)
Excluded (N=15) 
Breast cancer (N=1) 
Heart/lung operation (N=14) 
A matching reference group 
(3 reference subjects per patient) was 
established from the Danish Civil 
Registry (N=774) 
Figure 1 Inclusion and exclusion of women with and without breast cancer in the study.
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scommon features were found regarding the pain symptoms for this
subgroup.
DISCUSSION
To our knowledge, this is the first population-based study of
chronic pain after surgery for breast cancer that includes a
comparable reference group.
The prevalence of PMPS in this study was found to be 24% as
compared with PMPS-like symptoms in 10% of the reference
group. The odds ratio for developing PMPS after treatment for
breast cancer was 2.9. This prevalence for PMPS in women after
surgery for breast cancer is similar to results obtained by Smith
et al in (1999) (29%) and Carpenter et al in (1998) (27%).
In one study, the prevalence has been found to be higher in low
volume units than in high volume units (Tasmuth et al, 1999). The
prevalence of PMPS-like symptoms in women who had not had
Table 2 Possible risk factors for developing the postmastectomy pain syndrome (PMPS)
Univariate analysis Multivariate models
Logistic regression Logistic regression
Variable
Odds ratio of developing
PMPS (95% CI) P-value
Odds ratio of developing
PMPS (95% CI) P-value
Chemotherapy (CMF/CEF) 2.78 (1.29–6.02)* 0.01 1.63 (0.64–4.17) 0.31
Tumour located in the upper lateral quarter 2.78 (1.22–6.34)* 0.02 6.48 (2.24–18.77)* 0.00
Axillary dissection 2.03 (1.06–3.89)* 0.03 1.37 (0.58–3.19) 0.47
Young age 1.03 (1.01–1.05)* 0.03 1.04 (1.00–1.08)* 0.04
Mastectomy (vs lumpectomy) 2.01 (1.07–3.79)* 0.03 0.81 (0.25–2.69) 0.74
Smoking 2.03 (1.03–4.00)* 0.04 1.72 (0.75–3.96) 0.20
Having undergone breast surgery earlier 2.20 (0.99–4.90) 0.05 8.12 (2.39–27.64)* 0.001
Tumour size 1.02 (1.00–1.05) 0.05 1.02 (0.99–1.06) 0.18
Metastasis to the local lymph nodes 1.73 (0.80–3.39) 0.11
Positive oestrogen receptorstatus 0.55 (0.24–1.29) 0.17
Endocrine therapy 1.47 (0.68–3.20) 0.33
Radiation therapy 0.75 (0.40–1.42) 0.38 0.56 (0.20–1.56) 0.27
Grade of malignancy 1.18 (0.74–1.92) 0.48
Body mass index 1.00 (0.90–1.11) 0.95
List of possible risk factors determined by odds ratio. *Significant risk factor (Po0.05).
Table 3 Type of breast surgery and location of pain
Axillary intervention Mamma n (%) Shoulder, axilla and arm n (%) Any pain n (%)
Lumpectomy
No axillary intervention (n¼11) 0 (0) 1 (9.1) 1 (9.1)
Sentinel node (n¼64) 5 (7.8) 7 (10.9) 8 (12.5)
Axillary dissection (n¼46) 5 (10.9) 8 (28.3) 8 (28.3)
Mastectomy
No axillary intervention (n¼13) 2 (15.4) 3 (23.1) 3 (23.1)
Sentinel node (n¼16) 6 (37.5) 4 (25.0) 6 (37.5)
Axillary dissection (n¼69) 13 (19.1) 18 (26.5) 20 (29.4)
Table 4 Axillary intervention and location of pain
Axillary intervention Mamma, % (95% CI) Shoulder, axilla and arm, % (95% CI) Any pain, % (95% CI)
No axillary intervention (n¼24) 8.3 (1.0–27.0) 16.7 (4.7–37.4) 16.7 (4.7–37.4)
Sentinel node (n¼80) 13.8 (7.1–23.3) 13.8 (7.1–23.3) 17.5 (9.9–27.6)
Axillary dissection (n¼115) 16.5 (10.3–46.0) 27.8 (19.9–37.0) 29.6 (21.4–88.0)
Table 5 Radiation therapy and location of pain
Radiation therapy Mamma, % (95% CI) Shoulder, axilla and arm, % (95% CI) Any pain, % (95% CI)
No radiation therapy (n¼83) 8.3 (1.0–27.0) 16.7 (4.7–37.4) 16.7 (4.7–37.4)
Breast and clavicle (n¼91) 8.8 (7.0–21.9) 13.8 (7.1–23.3) 17.5 (9.9–27.6)
Breast and clavicle+medial axillary region (n¼32) 16.5 (10.3–4.6) 27.8 (19.9–37.0) 29.6 (21.4–8.8)
Breast and clavicle+ all the axillary region (n¼13) 30.8 (9.1–61.4) 53.8 (25.1–80.8) 53.8 (25.1–80.8)
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ssurgery for breast cancer is surprisingly high and mandates a
conservative view on the raw prevalence figures.
The surgical procedures used in the region in the period 2003–
2008 have remained principally unchanged. Mammographic
screening had been introduced 10 years earlier and thus resulted
in an increase in the number of women who could have breast-
conserving procedures. The sentinel node technique became more
widely used in the last part of the period and this has led to an
increase in axillary-sparing procedures.
Three risk factors for developing PMPS were identified in this
study: having undergone breast surgery earlier, tumour located in
the upper lateral quarter and young age. Earlier surgery in the
same breast appears to be a logical risk factor for PMPS. Regarding
the location of the tumour, previous studies have not evaluated
this variable as a risk factor. With tumours in close relation to the
axilla, there is a higher risk of damaging nerves in the area that
may increase the risk of subsequent chronic pain. Young age has
also been reported to be a predisposing factor to PMPS in other
studies (Tasmuth et al, 1995; Smith et al, 1999; Poleshuck et al,
2006). It has previously been suggested that this may be caused by
the more aggressive character of disease in this group of patients,
requiring more invasive surgical procedures and chemotherapy
(Kroman et al, 2000; Colleoni et al, 2002). However, in this study,
these factors are included in the multiple regression analysis, and
this indicates that other factors may account for the fact that PMPS
is seen more often among young patients.
Two possible risk factors, which have been considered
previously, are the sectioning of the intercostobrachial nerve
(Abdullah et al, 1998; Torresan et al, 2003) and axillary dissection
(Vecht, 1990; Maunsell et al, 1993; Hack et al, 1999; Kakuda et al,
1999; Johansen et al, 2000). However, one study has shown the
opposite result, with postmastectomy pain occurring without
damage to the intercostobrachial nerve and in women without
axillary dissection (Carpenter et al, 1999). In this study, it was not
possible to obtain information about the sectioning or preserva-
tion of the intercostobrachial nerve among the patients included.
Axillary dissection came out as a risk factor in univariate analysis,
but this effect could not be reproduced in the multivariate analysis.
We did not find any significant difference in the description of
pain between breast cancer patients and the reference group.
However, the location of the pain did differ between the two
groups, with the majority of the breast cancer patients having pain
in the shoulder, in the area of the scar and in more than one
location. These findings are in agreement with earlier findings
(Stevens et al, 1995; Carpenter et al, 1998). When using logistic
regression analysis, we found that pain located in the mamma was
seen approximately four times less frequent in the group of women
who had undergone lumpectomy compared with the women who
had undergone mastectomy. Sentinel node biopsy and axillary
dissection was not associated with a significant effect on this pain
location. Neither the type of breast surgery nor the type of axillary
intervention had a significant impact on the frequency of pain
located in the mamma. A similar pattern was observed for
radiation therapy. An increase in pain located in the breast and
especially pain located in the shoulder and arm was seen, when the
radiation field included supraclavicular glands and the axillary
region. A recent study, including 278 breast cancer patients, has
addressed the impact of different types of pain on the degree of
disability and distress (Kudel et al, 2007). Three types of pain were
studied: phantom breast pain, scar pain and other mastectomy-
related pain. In this study, ‘other mastectomy-related pain’ was
found to be the strongest predictor of disability and distress.
Demographic and surgical factors were not consistent predictors of
pain or function.
For this type of study, some methodological limitations must be
considered. The study group consisted of women who had
undergone treatment for breast cancer at one centre, a teaching
hospital, and all the women in the study group were Caucasian,
that is, we do not know if the figures can be generalised to other
settings. Further, it is possible that the percentage of women who
did not have PMPS or PMPS-like symptoms was higher in the
group of non-responders than in the group of responders. As the
response rates in the study group and in the control group were 85
and 73%, respectively, the prevalence of PMPS and the odds ratio
for developing PMPS may have been overestimated. There are no
specific questionnaires for identifying and evaluating pain after
surgery in breast cancer patients, and the questionnaires
developed for estimating neuropathic pain components (Bennett,
2001; Krause and Backonja, 2003; Bouhassira et al, 2005;
Freynhagen et al, 2006; Portenoy, 2006) were considered not to
be suited for the present purpose. Thus, we chose to make
a questionnaire specifically for this study and we have no data
to support its validity. Women with possible reoccurrence of
cancer were included in the study and this is a potential bias of the
results. The tumour itself may have caused pain and may thus have
caused a higher prevalence of pain in the breast cancer group.
Finally, our study comprised 219 patients, and the analysis of the
risk factors may have been hampered by the low number of
patients.
Chronic pain after surgery has been reported to develop in
5–60% of patients after operations such as thoracotomy, hip
arthroplasty, hysterectomy, thoracotomy and inguinal hernia
repair (Perttunen et al, 1999; Aasvang and Kehlet, 2005; Nikolajsen
et al, 2006; Maguire et al, 2006; Pluijms et al, 2006; Kehlet et al,
2006; Brandsborg et al, 2007). For hysterectomy, it was found that
about 14% had pelvic pain more than 2 days a week and risk
factors were preoperative pelvic pain, pain as the main indicator
for surgery and pain problems elsewhere (Brandsborg et al, 2007).
Pain after total hip arthroplasty, which limited daily living to a
moderate to very severe degree, occurred with a frequency of about
12%, and the risk factors were intensity of early postoperative pain
and pain complaints from other areas of the body (Nikolajsen et al,
2006). Prevalence of post-thoracotomy pain was observed to be
21%, when evaluated 6–7 years after surgery, and risk factors were
age, consultant and time since surgery (Maguire et al, 2006).
Only 22% of the breast cancer patients reported that the pain
had an impact on the daily life and use of analgesics was low. These
findings suggest that the severity of PMPS, in general, is moderate,
which is in agreement with earlier studies (de Vries et al, 1994).
The majority of the breast cancer patients with severe pain have
pain located in the shoulder, axilla or arm. This adds evidence to
0%
25%
50%
75%
100%
Breast cancer patients
Not at all A little Some Quite a lot Very much
Reference subjects
∗
Figure 2 The impact of pain on daily life. *Significant difference
(P¼0.0004).
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sthe finding of tumour located in the upper lateral quarter being an
important risk factor, as operation in this area may tend to cause
more nerve damage than surgery in other areas of the breast. This
finding has not been reported in earlier studies.
In conclusion, it seems that, although recent advances in the
diagnostic and surgical procedures have reduced the frequency of
the more invasive surgical procedures, there is still a considerable
risk of developing PMPS after treatment for breast cancer, and
development of preventive measures as well as treatments of the
syndrome are highly relevant.
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